AVIDITY BIOSCIENCES INC (RNA) Institutional Ownership
None of the superinvestors we track currently report AVIDITY BIOSCIENCES INC (RNA) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in AVIDITY BIOSCIENCES INC (RNA), this page will show smart money ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2025 | 1 | $3,253,063 | 45,100 |
| Q4 2024 | 1 | $6,141,696 | 211,200 |
| Q3 2024 | 1 | $6,517,467 | 141,900 |
| Q2 2024 | 1 | $15,416,790 | 377,400 |
| Q4 2023 | 1 | $2,052 | 226,700 |
| Q3 2023 | 1 | $707 | 110,800 |
| Q2 2023 | 1 | $731 | 65,900 |
| Q1 2023 | 1 | $5,758 | 375,100 |
| Q4 2022 | 1 | $3,697 | 166,600 |
| Q3 2022 | 1 | $2,025 | 124,000 |
| Q2 2022 | 1 | $1,574 | 108,300 |
| Q1 2022 | 1 | $709 | 38,400 |
Related RNA Institutional Insights:
- RNA Institutional Ownership & Insiders Activity
- RNA Institutional Ownership & 13F Activity
- RNA Top Institutional Shareholders
- RNA Institutional Buying Activity
- RNA Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- RNA Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings